(Q39607874)

13 September 2017

1 reference

title

Immune mechanisms in inflammatory polyneuropathy (English)

1 reference

13 September 2017

0 references

1

Hartung HP

1 reference

13 September 2017

Heininger K

2

1 reference

13 September 2017

Schäfer B

series ordinal

3

1 reference

13 September 2017

Fierz W

series ordinal

4

1 reference

13 September 2017

Toyka KV

series ordinal

5

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 January 1988

1 reference

Annals of the New York Academy of Sciences

13 September 2017

1 reference

13 September 2017

540

1 reference

13 September 2017

122-161

1 reference

The Landry-Guillain-barré syndrome. Complications, prognosis and natural history in 123 cases

13 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Axonal degeneration in demyelinating disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Conduction failure and nerve conduction slowing in experimental allergic neuritis induced by P2-specific T-cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Inflammatory neuropathy in homosexual men with lymphadenopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Inflammatory demyelinating peripheral neuropathies associated with human T-cell lymphotropic virus type III infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Treatment of the neuromuscular complications of human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Immunoreactive myelin basic protein in cerebrospinal fluid of patients with peripheral neuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Serum-mediated Schwann cell cytotoxicity in the Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Humoral factors in peripheral nerve disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Plasma proteins in human peripheral nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Tissue culture demyelination by normal human serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Anti-peripheral myelin antibody in patients with demyelinating neuropathy: quantitative and kinetic determination of serum antibody by complement component 1 fixation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Antibodies to glycolipids in demyelinating diseases of the human peripheral nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Serum antibodies to gangliosides in Guillain-Barré syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Transfer of demyelination by intraneul injection of experimental allergic neuritis serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Conduction block in rat myelinated fibres following acute exposure to anti-galactocerebroside serum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

The mouse blood-brain barrier and blood-nerve barrier for IgG: a tracer study by use of the avidin-biotin system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Endoneurial injection of antisera to myelin antigens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Induction of experimental allergic neuritis with a peptide from myelin P2 basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Identification of the neuritogen for experimental allergic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Immunologic studies of rabies vaccination-induced Guillain-Barré syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Complement depletion suppresses Lewis rat experimental allergic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Electron microscope observations on demyelination and remyelination in experimental allergic neuritis. I. Demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

The role of macrophages in experimental autoimmune neuritis induced by a P2-specific T-cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: A possible mechanism of inflammatory demyelination

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

The initial lesion in experimental allergic neuritis. A phase and electron microscopic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Blood-nerve barrier studies in experimental allergic neuritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Demyelination in allergic and Marke's disease virus induced neuritis comparative electron microscopic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Cultured human and rat oligodendrocytes and rat schwann cells do not have immune response gene associated antigen (Ia) on their surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Ciclosporin A prevents P2 T cell line-mediated experimental autoimmune neuritis (AT-EAN) in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

HLA typing and Guillain-Barre syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

A critical review of therapies in acute and chronic inflammatory demyelinating polyneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Motor conduction studies in Guillain-Barré syndrome: description and prognostic value.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

The use of steroids in the treatment of idiopathic polyneuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Controlled trial prednisolone in acute polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Plasma and gamma-globulin infusion in chronic inflammatory polyneuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Suppression of experimental allergic neuritis by Cyclosporin-A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Chronic relapsing (Dysimmune) polyneuropathy: Pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Chronic relapsing demyelinating polyneuropathy associated with hepatitis B infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Peripheral neuropathies associated with monoclonal proteins: a clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Peripheral neuropathy associated with monoclonal IgM autoantibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Monoclonal gammopathy and neuropathy: myelin-associated glycoprotein reactivity and clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

The neuropathy of plasma cell dyscrasia: binding of IgM M-proteins to peripheral nerve glycolipids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Monoclonal IgM in a patient with paraproteinemic polyneuropathy binds to gangliosides containing disialosyl groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Neuronal antinuclear antibody in sensory neuronopathy from lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Sensory neuronopathy and small cell lung cancer. Antineuronal antibody that also reacts with the tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Immunoglobulin abnormalities in cerebrospinal fluid and blood over the course of lymphocytic meningoradiculitis (Bannwarth's syndrome).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Ultrastructural and histophysiological studies on the blood-nerve barrier and perineurial barrier in leprosy neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Defective gamma interferon production in leprosy. Reversal with antigen and interleukin 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Cloned suppressor T cells from a lepromatous leprosy patient suppress Mycobacterium leprae reactive helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Dynamics of Ia-expressing cells and T lymphocytes of different subsets during experimental allergic neuritis in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

T-Lymphocyte subsets, functional deficits, and morphology in sciatic nerves during experimental allergic neuritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

In Vivo Treatment of Rats with Monoclonal Anti-T-Cell Antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

Genetically restricted suppressor T-cell clones derived from lepromatous leprosy lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1988.TB27058.X

10.1111/J.1749-6632.1988.TB27058.X

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference